Accurate assessment of renal function is critical in the management of renal cell carcinoma (RCC), influencing surgical planning, systemic therapy eligibility, and clinical trial inclusion. Estimated ...
You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I am 81 years old and in excellent health. My blood pressure ...
Susceptibility to renal disease after low birth weight (LBW) is thought to be an additional dimension to the Barker hypothesis of prenatal programming of adult diseases (1,2). Inclusion criteria were ...
New research reveals that contrary toconventional belief, primary glomerular diseases are not necessarily benign for children and young adults. In fact, some subsets of children and young adults may ...
New research reveals that contrary to conventional belief, primary glomerular diseases are not necessarily benign for children and young adults. In fact, some subsets of children and young adults may ...
September 13, 2006 — Macroalbuminuria was a better population-screening marker than low estimated glomerular filtration rate (eGFR) or erythrocyturia to identify individuals who subsequently lost ...
No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2007 ASCO Annual Meeting. This abstract does not include a full text component.
The current guideline-recommended creatinine-based eGFR equation incorporates a race coefficient that may overestimate eGFR in Black adults and contribute to discordant care. Among equations for ...
Please provide your email address to receive an email when new articles are posted on . Treatment of glomerular disease has a hard endpoint, Brad H. Rovin, MD, FACP, FASN, said — slowing progression ...
Each kidney is made up of approximately one million glomeruli. These filter nitrogenous wastes (like urea and creatinine) from the blood, passing through the tuft of capillaries that make up a ...
The FDA has approved MediBeacon®'s TGFR system for noninvasive kidney function assessment, targeting both normal and impaired renal patients. INNOVATE Corp. announced the FDA approval of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results